Willingness to pay for antenatal carrier screening for cystic fibrosis.
We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.
Donaldson
C
C
Health Economics Research Unit, University of Aberdeen, Scotland.
Shackley
P
P
Abdalla
M
M
Miedzybrodzka
Z
Z
D000025:Abortion, Eugenic; D001294:Attitude to Health; D003550:Cystic Fibrosis / Q000517:prevention & control*; D030881:Disclosure; D016002:Discriminant Analysis; D005251:Fees, Medical; D005260:Female; D006580:Genetic Carrier Screening; D005817:Genetic Counseling / Q000379:methods; D006801:Humans; D008297:Male; D011247:Pregnancy; D037841:Pregnant People; D011296:Prenatal Diagnosis / Q000191:economics*; D012606:Scotland; D012747:Sexual Partners; D012959:Socioeconomic Factors; D013997:Time Factors; D014342:Truth Disclosure